Selvaraj P, Rosse W F, Silber R, Springer T A
Laboratory of Membrane Immunochemistry, Dana Farber Cancer Institute, Boston, Massachusetts.
Nature. 1988 Jun 9;333(6173):565-7. doi: 10.1038/333565a0.
Fc receptors on phagocytic cells in the blood mediate binding and clearance of immune complexes, phagocytosis of antibody-opsonized microorganisms, and potently trigger effector functions, including superoxide anion production and antibody-dependent cellular cytotoxicity. The Fc receptor type III (Fc gamma R III, CD 16), present in 135,000 sites per cell 1 on neutrophils and accounting for most of FcR in blood, unexpectedly has a phosphatidylinositol glycan (PIG) membrane anchor. Deficiency of Fc gamma R III is observed in paroxysmal nocturnal haemoglobinuria (PNH), an acquired abnormality of haematopoietic cells affecting PIG tail biosynthesis or attachment, and is probably responsible for circulating immune complexes and susceptibility to bacterial infections associated with this disease. Although a growing number of eukaryotic cell-surface proteins with PIG-tails are being described, none has thus far been implicated in receptor-mediated endocytosis or in triggering of cell-mediated killing. Our findings on the Fc gamma R III raise the question of how a PIG-tailed protein important in immune complex clearance in vivo and in antibody-dependent killing mediates ligand internalization and cytotoxicity. Together with our results, previous functional studies on Fc gamma R III and Fc gamma R II suggest that these two receptors may cooperate and that the type of membrane anchor is an important mechanism whereby the functional capacity of surface receptors can be regulated.
血液中吞噬细胞上的Fc受体介导免疫复合物的结合与清除、抗体调理微生物的吞噬作用,并有力地触发效应功能,包括超氧阴离子的产生和抗体依赖性细胞毒性。III型Fc受体(FcγR III,CD 16),在中性粒细胞上每个细胞有135,000个位点,占血液中FcR的大部分,意外地具有磷脂酰肌醇聚糖(PIG)膜锚定。在阵发性夜间血红蛋白尿(PNH)中观察到FcγR III缺乏,这是一种造血细胞的后天异常,影响PIG尾部生物合成或附着,可能与该疾病相关的循环免疫复合物和易患细菌感染有关。尽管越来越多具有PIG尾的真核细胞表面蛋白被描述,但迄今为止尚无一种与受体介导的内吞作用或细胞介导杀伤的触发有关。我们关于FcγR III的发现提出了一个问题,即一种在体内免疫复合物清除和抗体依赖性杀伤中起重要作用的PIG尾蛋白如何介导配体内化和细胞毒性。结合我们的结果,先前对FcγR III和FcγR II的功能研究表明这两种受体可能协同作用,并且膜锚定类型是调节表面受体功能能力的重要机制。